Phreesia [PHR] vs Certara [CERT] Detailed Stock Comparison
Phreesia
NYSE
Loading...
Certara
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Phreesia wins in 9 metrics, Certara wins in 8 metrics, with 0 ties. Phreesia appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Phreesia | Certara | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 218.80 | N/A |
| Price-to-Book Ratio | 5.34 | 1.64 | Certara |
| Debt-to-Equity Ratio | 2.60 | 29.00 | Phreesia |
| PEG Ratio | -40.10 | 21.88 | Phreesia |
| EV/EBITDA | -27.85 | 18.19 | Phreesia |
| Profit Margin (TTM) | -13.94% | 1.97% | Certara |
| Operating Margin (TTM) | -46.68% | 4.97% | Certara |
| EBITDA Margin (TTM) | N/A | 4.97% | N/A |
| Return on Equity | -22.67% | 0.75% | Certara |
| Return on Assets (TTM) | -8.75% | 1.31% | Certara |
| Free Cash Flow (TTM) | $8.29M | $59.43M | Certara |
| 1-Year Return | 16.83% | -12.55% | Phreesia |
| Price-to-Sales Ratio (TTM) | 3.41 | 4.33 | Phreesia |
| Enterprise Value | $986.85M | $1.90B | Certara |
| EV/Revenue Ratio | 2.35 | 4.69 | Phreesia |
| Gross Profit Margin (TTM) | 69.40% | 61.06% | Phreesia |
| Revenue per Share (TTM) | $7 | $3 | Phreesia |
| Earnings per Share (Diluted) | $-1.02 | $0.05 | Certara |
| Beta (Stock Volatility) | 0.74 | 1.42 | Phreesia |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Phreesia vs Certara Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Phreesia | 0.63% | 2.54% | -4.93% | 6.42% | -6.80% | 7.23% |
| Certara | -2.84% | 14.68% | -4.04% | -7.83% | -21.86% | 2.63% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Phreesia | 16.83% | 4.53% | -9.48% | 12.54% | 12.54% | 12.54% |
| Certara | -12.55% | -37.70% | -71.27% | -71.27% | -71.27% | -71.27% |
Performance & Financial Health Analysis: Phreesia vs Certara
| Metric | PHR | CERT |
|---|---|---|
| Market Information | ||
| Market Cap | $1.43B | $1.76B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 403,230 | 1,630,680 |
| 90 Day Avg. Volume | 422,913 | 1,683,130 |
| Last Close | $27.01 | $10.94 |
| 52 Week Range | $17.07 - $30.53 | $8.64 - $15.69 |
| % from 52W High | -11.53% | -30.27% |
| All-Time High | $81.59 (Feb 08, 2021) | $45.48 (Nov 01, 2021) |
| % from All-Time High | -66.90% | -75.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.46% | 0.12% |
| Quarterly Earnings Growth | 0.15% | 0.12% |
| Financial Health | ||
| Profit Margin (TTM) | -0.14% | 0.02% |
| Operating Margin (TTM) | -0.47% | 0.05% |
| Return on Equity (TTM) | -0.23% | 0.01% |
| Debt to Equity (MRQ) | 2.60 | 29.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $4.51 | $6.67 |
| Cash per Share (MRQ) | $7.48 | $1.02 |
| Operating Cash Flow (TTM) | $32.38M | $101.55M |
| Levered Free Cash Flow (TTM) | $28.64M | $78.79M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Phreesia vs Certara
| Metric | PHR | CERT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 218.80 |
| Forward P/E | -40.10 | 21.88 |
| PEG Ratio | -40.10 | 21.88 |
| Price to Sales (TTM) | 3.41 | 4.33 |
| Price to Book (MRQ) | 5.34 | 1.64 |
| Market Capitalization | ||
| Market Capitalization | $1.43B | $1.76B |
| Enterprise Value | $986.85M | $1.90B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.35 | 4.69 |
| Enterprise to EBITDA | -27.85 | 18.19 |
| Risk & Other Metrics | ||
| Beta | 0.74 | 1.42 |
| Book Value per Share (MRQ) | $4.51 | $6.67 |
Financial Statements Comparison: Phreesia vs Certara
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PHR | CERT |
|---|---|---|
| Revenue/Sales | $109.68M | $106.00M |
| Cost of Goods Sold | $33.57M | $41.52M |
| Gross Profit | $76.12M | $64.48M |
| Research & Development | $29.63M | $10.52M |
| Operating Income (EBIT) | $-7.61M | $7.62M |
| EBITDA | $2.03M | $27.96M |
| Pre-Tax Income | $-5.38M | $4.54M |
| Income Tax | $1.01M | $-201,000 |
| Net Income (Profit) | $-6.39M | $4.74M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PHR | CERT |
|---|---|---|
| Cash & Equivalents | $84.22M | $179.09M |
| Total Current Assets | $203.29M | $300.18M |
| Total Current Liabilities | $114.02M | $108.08M |
| Long-Term Debt | $8.80M | $301.63M |
| Total Shareholders Equity | $264.81M | $1.08B |
| Retained Earnings | $-801.50M | $-123.54M |
| Property, Plant & Equipment | $17.24M | $15.12M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PHR | CERT |
|---|---|---|
| Operating Cash Flow | $15.59M | $15.22M |
| Capital Expenditures | $-2.79M | N/A |
| Free Cash Flow | $9.20M | $11.58M |
| Debt Repayment | $-2.64M | $-750,000 |
| Common Stock Repurchase | $0 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PHR | CERT |
|---|---|---|
| Shares Short | 2.34M | 9.83M |
| Short Ratio | 4.77 | 5.17 |
| Short % of Float | 0.05% | 0.08% |
| Average Daily Volume (10 Day) | 403,230 | 1,630,680 |
| Average Daily Volume (90 Day) | 422,913 | 1,683,130 |
| Shares Outstanding | 58.73M | 161.01M |
| Float Shares | 56.03M | 120.63M |
| % Held by Insiders | 0.04% | 0.03% |
| % Held by Institutions | 0.97% | 1.02% |
Dividend Analysis & Yield Comparison: Phreesia vs Certara
| Metric | PHR | CERT |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |